Intralytix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Intralytix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11488
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intralytix Inc (Intralytix) is a biotechnology company that develops, produces and markets bacteriophage based products to control bacterial pathogens. The company offers food safety products, pet food safety products and pre-harvest interventions. Its food safety products include listshield, ecoshield, salmofresh and shigashield. Intralytix food safety products help prevent Listeria monocytogenes and Escherichia coli contamination in food and food processing facilities. Its animal health products are effective against Clostridium perfringens contamination in live poultry. The company also commercializes its bacteriophage technology for use in food production and processing, environmental cleanliness, veterinary applications and human therapy. Intralytix is headquartered in Baltimore, Maryland, the US.

Intralytix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intralytix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intralytix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intralytix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Intralytix Raises USD17.5 Million in Venture Financing 10
Partnerships 11
Intralytix Enters into Partnership with BioPhage Therapeutics 11
Ferring Pharma Enters into Agreement with Intralytix 12
Ferring Pharma Enters into Co-Development Agreement with Intralytix 13
Intralytix Inc – Key Competitors 14
Intralytix Inc – Key Employees 15
Intralytix Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Intralytix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intralytix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intralytix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Intralytix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intralytix Raises USD17.5 Million in Venture Financing 10
Intralytix Enters into Partnership with BioPhage Therapeutics 11
Ferring Pharma Enters into Agreement with Intralytix 12
Ferring Pharma Enters into Co-Development Agreement with Intralytix 13
Intralytix Inc, Key Competitors 14
Intralytix Inc, Key Employees 15

List of Figures
Intralytix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intralytix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intralytix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Intralytix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Vedanta Resources Plc:企業のM&A・事業提携・投資動向
    Vedanta Resources Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Resources Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oil States Industries Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Oil States Industries Inc (Oil States), a subsidiary of Oil States International Inc, is a provider of intergrated energy systems and solutions that offers oil and gas products and services. The company provides products in the areas of offshore, onshore, marine and industrial areas, among o …
  • Linde AG, Engineering:企業の戦略的SWOT分析
    Linde AG, Engineering - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sumitomo Electric Industries Ltd (5802)-エネルギー分野:企業M&A・提携分析
    Summary Sumitomo Electric Industries, Ltd. (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, infocommunications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses …
  • Amer Sports Corporation:企業の戦略・SWOT・財務情報
    Amer Sports Corporation - Strategy, SWOT and Corporate Finance Report Summary Amer Sports Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AyoxxA Biosystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing …
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • PT Telekomunikasi Indonesia, Tbk:企業の戦略・SWOT・財務情報
    PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Telekomunikasi Indonesia, Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ResCare Inc:企業の戦略的SWOT分析
    ResCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hyduke Energy Services Inc (HYD)-石油・ガス分野:企業M&A・提携分析
    Summary Hyduke Energy Services Inc. (Hyduke) is an integrated oilfield services company that manufacture, repair and distributes oilfield equipment and supplies. It carries out the engineering, design and manufacture of land-based drilling rigs, service rigs, coiled tubing units, pump units, cranes, …
  • Shermco Industries, Inc.:電力:M&Aディール及び事業提携情報
    Summary Shermco Industries, Inc. (Shermco), a member of the GFI Energy Group of Oaktree Capital Management LP, is an independent service company that provides electrical maintenance, repair, testing, and analysis services for electrical systems and equipment. It also offers industrial contracting, u …
  • Yoshinoya Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Augmenix Inc-医療機器分野:企業M&A・提携分析
    Summary Augmenix Inc (Augmenix) is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications. The company offers products such as hydrogel products, space OAR systems, absorbable tissue marker, and trace-IT hydrogel products. Its TraceIT hyd …
  • IDACORP, Inc.:企業の戦略・SWOT・財務分析
    IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a biotechnology company which develops novel medicines for cancer treatment. The company is investigating OmniCAR, an immune receptor platform that controls T-cell activity and multi-antigen targeting with a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆